Robert B Bazemore Epizyme, Inc. (EPZM) insider trading activity

Robert B Bazemore is President & CEO of Epizyme, Inc.. Currently has a direct ownership of 322,626 shares of EPZM, which is worth approximately $0. The most recent transaction as insider was on Mar 25, 2021, when has been sold 10,328 shares (Common Stock, par value $0.0001) at a price of $7.85 per share, resulting in proceeds of $81,075. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 323K

0% 3M change

0% 12M change

Total Value Held $0

Robert B Bazemore Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 25 2021	SELL Open market or private sale	$81,075 $7.85 p/Share	10,328 Reduced 3.1%	322,626 Common Stock, par valu...
Feb 04 2021	SELL Open market or private sale	$43,607 $11.21 p/Share	3,890 Reduced 1.16%	331,977 Common Stock, par valu...
Feb 01 2021	BUY Grant, award, or other acquisition	-	87,500 Added 20.67%	335,867 Common Stock
Jan 25 2021	SELL Open market or private sale	$69,247 $11.41 p/Share	6,069 Reduced 2.39%	248,367 Common Stock, par valu...

Also insider at

NUVB

Nuvation Bio Inc. Healthcare

ARDX

ARDELYX, INC. Healthcare

Director

AKTX

Akari Therapeutics Plc Healthcare

RBB